Tarsus Pharmaceuticals, Inc. (TARS)
81.28
-0.04
(-0.05%)
USD |
NASDAQ |
Dec 11, 13:14
Tarsus Pharmaceuticals Total Assets (Quarterly): 534.56M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 3.033B |
| Codexis, Inc. | 123.96M |
| Precigen, Inc. | 171.26M |
| Celcuity, Inc. | 476.00M |
| Liquidia Corp. | 275.98M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 199.48M |
| Shareholders Equity (Quarterly) | 335.08M |
| Debt to Equity Ratio | 0.2462 |
| Current Ratio | 4.286 |
| Net Debt Paydown Yield | -0.08% |